Alyeska Investment Group, L.P. Sol Gel Technologies Ltd. Transaction History

Alyeska Investment Group, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	BUY	$7.5 - $10.71 $14,745 - $21,055	1,966 Added 3.31%	61,429 $474,000
Q1 2018 May 15, 2018	BUY	$10.3 - $13.64 $612,468 - $811,075	59,463 New	59,463 $612,000

7.34M

5.4K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $15M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.